Annual CFI
$121.41 M
+$342.52 M+154.91%
December 31, 2024
Summary
- As of March 13, 2025, ABCL annual cash flow from investing activities is $121.41 million, with the most recent change of +$342.52 million (+154.91%) on December 31, 2024.
- During the last 3 years, ABCL annual CFI has risen by +$453.66 million (+136.54%).
- ABCL annual CFI is now at all-time high.
Performance
ABCL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$35.70 M
+$32.01 M+865.47%
December 31, 2024
Summary
- As of March 13, 2025, ABCL quarterly cash flow from investing activities is $35.70 million, with the most recent change of +$32.01 million (+865.47%) on December 31, 2024.
- Over the past year, ABCL quarterly CFI has increased by +$32.01 million (+865.47%).
- ABCL quarterly CFI is now -31.47% below its all-time high of $52.10 million, reached on June 30, 2024.
Performance
ABCL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$121.41 M
+$60.03 M+97.79%
December 31, 2024
Summary
- As of March 13, 2025, ABCL TTM cash flow from investing activities is $121.41 million, with the most recent change of +$60.03 million (+97.79%) on December 31, 2024.
- Over the past year, ABCL TTM CFI has increased by +$60.03 million (+97.79%).
- ABCL TTM CFI is now at all-time high.
Performance
ABCL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ABCL Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +154.9% | +865.5% | +97.8% |
| 3 y3 years | +136.5% | +865.5% | +97.8% |
| 5 y5 years | +2200.5% | +865.5% | +97.8% |
ABCL Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.4% | -31.5% | +112.7% | at high | +125.1% |
| 5 y | 5-year | at high | +134.4% | -31.5% | +112.7% | at high | +125.1% |
| alltime | all time | at high | +134.4% | -31.5% | +112.7% | at high | +125.1% |
AbCellera Biologics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $121.41 M(-154.9%) | $35.70 M(+865.5%) | $121.41 M(+97.8%) |
| Sep 2024 | - | $3.70 M(-92.9%) | $61.38 M(+36.7%) |
| Jun 2024 | - | $52.10 M(+74.2%) | $44.90 M(-208.0%) |
| Mar 2024 | - | $29.91 M(-223.0%) | -$41.59 M(-81.2%) |
| Dec 2023 | -$221.11 M(-37.3%) | -$24.32 M(+90.2%) | -$221.11 M(+3.4%) |
| Sep 2023 | - | -$12.79 M(-62.8%) | -$213.85 M(-55.7%) |
| Jun 2023 | - | -$34.39 M(-77.0%) | -$483.06 M(+1.5%) |
| Mar 2023 | - | -$149.61 M(+776.8%) | -$475.86 M(+34.9%) |
| Dec 2022 | -$352.63 M | -$17.06 M(-93.9%) | -$352.63 M(+4.7%) |
| Sep 2022 | - | -$281.99 M(+936.9%) | -$336.71 M(+3.8%) |
| Jun 2022 | - | -$27.20 M(+3.1%) | -$324.34 M(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$26.37 M(+2195.1%) | -$342.78 M(+3.2%) |
| Dec 2021 | -$332.25 M(+177.4%) | -$1.15 M(-99.6%) | -$332.25 M(-24.4%) |
| Sep 2021 | - | -$269.63 M(+490.9%) | -$439.28 M(+153.1%) |
| Jun 2021 | - | -$45.63 M(+188.1%) | -$173.54 M(+33.5%) |
| Mar 2021 | - | -$15.84 M(-85.4%) | -$130.04 M(+8.6%) |
| Dec 2020 | -$119.78 M(+1972.3%) | -$108.18 M(+2684.6%) | -$119.78 M(+932.8%) |
| Sep 2020 | - | -$3.88 M(+82.4%) | -$11.60 M(+50.4%) |
| Jun 2020 | - | -$2.13 M(-61.8%) | -$7.71 M(+38.2%) |
| Mar 2020 | - | -$5.58 M | -$5.58 M |
| Dec 2019 | -$5.78 M(+8.9%) | - | - |
| Dec 2018 | -$5.31 M | - | - |
FAQ
- What is AbCellera Biologics annual cash flow from investing activities?
- What is the all time high annual CFI for AbCellera Biologics?
- What is AbCellera Biologics annual CFI year-on-year change?
- What is AbCellera Biologics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AbCellera Biologics?
- What is AbCellera Biologics quarterly CFI year-on-year change?
- What is AbCellera Biologics TTM cash flow from investing activities?
- What is the all time high TTM CFI for AbCellera Biologics?
- What is AbCellera Biologics TTM CFI year-on-year change?
What is AbCellera Biologics annual cash flow from investing activities?
The current annual CFI of ABCL is $121.41 M
What is the all time high annual CFI for AbCellera Biologics?
AbCellera Biologics all-time high annual cash flow from investing activities is $121.41 M
What is AbCellera Biologics annual CFI year-on-year change?
Over the past year, ABCL annual cash flow from investing activities has changed by +$342.52 M (+154.91%)
What is AbCellera Biologics quarterly cash flow from investing activities?
The current quarterly CFI of ABCL is $35.70 M
What is the all time high quarterly CFI for AbCellera Biologics?
AbCellera Biologics all-time high quarterly cash flow from investing activities is $52.10 M
What is AbCellera Biologics quarterly CFI year-on-year change?
Over the past year, ABCL quarterly cash flow from investing activities has changed by +$32.01 M (+865.47%)
What is AbCellera Biologics TTM cash flow from investing activities?
The current TTM CFI of ABCL is $121.41 M
What is the all time high TTM CFI for AbCellera Biologics?
AbCellera Biologics all-time high TTM cash flow from investing activities is $121.41 M
What is AbCellera Biologics TTM CFI year-on-year change?
Over the past year, ABCL TTM cash flow from investing activities has changed by +$60.03 M (+97.79%)